News

Public · Published

Syra Health 3Q 2026: Revenue $2.56M, Net income $345K, EPS $0.02— 10-Q Summary

Syra Health reported third-quarter 2026 revenue of $2.56 million, up 51.5% from a year earlier, and net income of $345,000, versus a $226,000 loss. Diluted earnings per share, or profit allocated to each share, were $0.02, compared with a $0.02 loss per share.

Published:

Updated:

What happened

Syra Health reported third-quarter 2026 revenue of $2.56 million, up 51.5% from a year earlier, and net income of $345,000, versus a $226,000 loss. Diluted earnings per share, or profit allocated to each share, were $0.02, compared with a $0.02 loss per share.

Confirmed

Global impact / market context

The move from a loss to a profit, alongside higher revenue, indicates improved reported results. Population health services and additional nursing personnel under existing contracts supported growth, while delayed or canceled federal awards could reduce contract volume or shift when revenue is recorded.

Analyst inference

The article describes growth from healthcare staffing and population health work, but also flags uncertainty from federal spending reviews. If awards are delayed or requests canceled, contract-based revenue may arrive later or decline, making continued growth and profitability less certain.

Analyst inference

What to watch

  1. Check whether the next reported quarter shows revenue growth continuing and net income remaining positive; the article gives no forecast for either measure. Analyst inference
  2. Watch for updates on federal spending reviews and contract awards, since the article says delays or canceled requests may affect contract volume and revenue timing. Confirmed
  3. Look for further results from population health services and staffing under existing contracts, which the article identifies as contributors to revenue growth and stronger margins. Analyst inference

Evidence

  • Original source link unavailable